コネチカット州における頭頸部扁平上皮癌の臨床試験
コネチカット州内の拠点で、頭頸部扁平上皮癌に関する24件の研究が参加者を募集しています。
コネチカット州内の都市
公式研究テキスト（英語）
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #62, New Haven
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07090499Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
- Yale University - Yale University School of Medicine, New Haven
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07360314A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
- Hartford Hospital, Hartford
- Yale Cancer Center, New Haven
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07276399A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
- Yale Cancer Center, New Haven
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06385080A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Kivu Trial Site, New Have
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/24更新 · NCT07229313Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull
- 他1件
被験者募集中第2相
18歳〜79歳 · 全性別 · 2026/09/22更新 · NCT04671667Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Yale University, Yale Cancer Center, New Haven
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05983432Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- Smilow Cancer Hospital Care Center at Greenwich, Greenwich
- Smilow Cancer Hospital Care Center - Guilford, Guilford
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- 他4件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT02734537First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
- Yale Cancer Center, New Haven
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06657222ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
- Yale University Cancer Center, New Haven
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06597721A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, New Haven
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07182149Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- Yale University, New Haven
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT04333537CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs
- Yale University, New Haven
被験者募集中第2相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/07/30更新 · NCT07172256A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
- Yale Comprehensive Cancer Center, New Haven
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/29更新 · NCT06747585Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- Yale University, Yale Cancer Center, New Haven
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/23更新 · NCT069938445-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC
- Yale University, New Haven
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/10更新 · NCT05317000Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- Yale University School of Medicine /ID# 225707, New Haven
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/04更新 · NCT04777994A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- GSK Investigational Site, Farmington
- GSK Investigational Site, New Haven
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/26更新 · NCT06256588A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- Yale School of Medicine - Smilow Cancer Hospital, New Haven
被験者募集中第3相
18歳以上 · 全性別 · 2026/04/09更新 · NCT06064877VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Hartford Hospital (site 210), Hartford
被験者募集中第1/2相
18歳〜80歳 · 全性別 · 2025/12/11更新 · NCT03556228A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
- Yale Cancer Center, New Haven
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/11/04更新 · NCT05902988Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- Yale Cancer Center, New Haven
被験者募集中第1/2相
18歳以上 · 全性別 · 2024/11/15更新 · NCT04787042Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
- Yale, New Haven
被験者募集中第2相
18歳以上 · 全性別 · 2024/03/18更新 · NCT05280314ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。